Answers are grounded in this paper and cite their sources.
This study demonstrates metabolic and functional network dynamics in Parkinson's disease using PET/MR, indicating potential diagnostic biomarkers.
Parkinson's disease (PD) is a neurodegenerative disorder linked to altered cerebral glucose metabolism detectable via 18F-FDG-PET. This study integrated PET/MR and Jensen-Shannon similarity estimation (JSSE) to investigate metabolic/functional network dynamics in PD. 25 PD patients and 16 age/sex-matched normal controls (NCs) underwent visual analysis, standardized uptake value ratio (SUVR) comparisons, and JSSE-based metabolic/functional network construction. Topological properties, regional connectivity, and metabolic-functional correlations were analyzed. A support vector machine (SVM) model incorporating these features differentiated PD from NC. PD patients exhibited elevated SUVR in temporal and thalamic regions but reduced SUVR in parietal/precentral areas. Metabolic networks in PD showed increased assortativity yet decreased normalized clustering coefficients and disrupted small-worldness. Ten metabolic connections were impaired, with the left caudate-temporal pathway showing the strongest reduction. PD demonstrated significantly higher metabolic-functional network correlations than NCs. Machine learning identified metabolic network connectivity as the optimal classifier (AUC = 0.91). Our findings reveal PD-associated metabolic reorganization and validate PET/MR-derived network features as potential biomarkers. The multimodal framework advances pathophysiological understanding through network-level metabolic-functional interplay analysis, offering novel insights into PD diagnostics and mechanistic research.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: